Efficacy of Osimertinib in Patients With Postoperative Recurrent Non–Small‐Cell Lung Cancer Harboring Sensitizing EGFR Mutations
Yuko Iida, Hirotsugu Kenmotsu, Keita Mori, Meiko Morita et autres
jp (code pays fourni par la source)
0 citations
Thoracic Cancer